Biocryst Pharmaceuticals (BCRX) Q1 2026 Earnings

26FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.08
0.32
0.72
1.12

Details

Expected EPS
0.048275
Actual EPS
1.12
Surprise EPS
1.07
Surprise Percent
+2,220.04%

Description

Biocryst Pharmaceuticals (BCRX) has reported earnings of 1.12 per share for Q1 2026.

0 Comments

Share your thoughts